| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9115098 | Journal of Diabetes and its Complications | 2005 | 7 Pages |
Abstract
From this preliminary safety study, it appears that QR-333 may safely offer relief of symptoms of diabetic neuropathy and improve quality of life. These findings warrant further investigation of this topical compound.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Paul Valensi, Claude Le Devehat, Jean-Louis Richard, Cherifo Farez, Taraneh Khodabandehlou, Richard A. Rosenbloom, Carolyn LeFante,